Cranberry is a modern hybrid-indica cultivar developed from a genetic cross between Sunset Sherbert and Kimbo Kush. This strain is cultivated both indoors and outdoors, typically requiring a flowering period of approximately 66 days to reach maturity. While it is classified as a moderate challenge for growers, the plant is known to provide a high yield, and it has successfully contributed to the development of subsequent genetics such as its notable offspring, Royal Cranberry.

The terpene profile of Cranberry is characterized by a specific hierarchy of aromatic compounds, beginning with a dominance of caryophyllene, limonene, and myrcene. This complex chemical foundation is further nuanced by secondary and tertiary contributions from linalool, humulene, ocimene, isopulegol, beta-pinene, and pinene. Less prevalent notes of caryophyllene-oxide, geraniol, nerolidol, eucalyptol, bisabolol, camphene, guaiol, and p-cymene complete the profile to define its sensory experience.

As a THC-dominant cultivar, Cranberry is primarily utilized by users seeking to achieve states of relaxation, calmness, and focus. These effects make it a consistent choice for individuals addressing common concerns like physical pain, chronic stress, or difficulties with sleep. Beyond its immediate user applications, the strain maintains a distinct place within contemporary cannabis collections as the foundational parent for lines such as Royal Cranberry.